Flex Biomedical Receives $866,000 New Funding Round

  • Feed Type
  • Date
    1/27/2011
  • Company Name
    Flex Biomedical
  • Mailing Address
    505 S. Rosa Road Madison, WI 53719
  • Company Description
    Flex Biomedical’s lead product is a synthetic polymer, the Flex Polymer, designed to treat osteoarthritis, an incurable joint disease that affects millions around the world.
  • Website
    http://www.flexbio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $866,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Both new and existing investors participated in the round, which will be used to continue developing the Flex Polymer, a synthetic polymer viscosupplement for the treatment of osteoarthritis.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.